Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

The growing epidemic of hypertension among children and adolescents: a challenging road ahead.

Assadi F.

Pediatr Cardiol. 2012 Oct;33(7):1013-20. doi: 10.1007/s00246-012-0333-5. Epub 2012 May 8. Review.

PMID:
22565200
2.

The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II - Therapy.

Khan NA, McAlister FA, Rabkin SW, Padwal R, Feldman RD, Campbell NR, Leiter LA, Lewanczuk RZ, Schiffrin EL, Hill MD, Arnold M, Moe G, Campbell TS, Herbert C, Milot A, Stone JA, Burgess E, Hemmelgarn B, Jones C, Larochelle P, Ogilvie RI, Houlden R, Herman RJ, Hamet P, Fodor G, Carruthers G, Culleton B, Dechamplain J, Pylypchuk G, Logan AG, Gledhill N, Petrella R, Tobe S, Touyz RM; Canadian Hypertension Education Program.

Can J Cardiol. 2006 May 15;22(7):583-93.

3.

Treatment of hypertension in chronic kidney disease.

Toto RD.

Semin Nephrol. 2005 Nov;25(6):435-9. Review.

PMID:
16298269
4.
5.

Measurement and treatment of elevated blood pressure in the pediatric patient with chronic kidney disease.

Swinford RD, Portman RJ.

Adv Chronic Kidney Dis. 2004 Apr;11(2):143-61. Review.

PMID:
15216486
6.

High blood pressure in children and adolescents.

Riley M, Bluhm B.

Am Fam Physician. 2012 Apr 1;85(7):693-700. Review.

7.

The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.

Khan NA, McAlister FA, Campbell NR, Feldman RD, Rabkin S, Mahon J, Lewanczuk R, Zarnke KB, Hemmelgarn B, Lebel M, Levine M, Herbert C; Canadian Hypertension Education Program.

Can J Cardiol. 2004 Jan;20(1):41-54.

PMID:
14968142
8.

[Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].

Cases Amenós A, Goicoechea Diezhandiño M, de Alvaro Moreno F.

Nefrologia. 2008;28 Suppl 3:39-48. Spanish.

9.

The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy.

Khan NA, McAlister FA, Lewanczuk RZ, Touyz RM, Padwal R, Rabkin SW, Leiter LA, Lebel M, Herbert C, Schiffrin EL, Herman RJ, Hamet P, Fodor G, Carruthers G, Culleton B, DeChamplain J, Pylypchuk G, Logan AG, Gledhill N, Petrella R, Campbell NR, Arnold M, Moe G, Hill MD, Jones C, Larochelle P, Ogilvie RI, Tobe S, Houlden R, Burgess E, Feldman RD; Canadian Hypertension Education Program.

Can J Cardiol. 2005 Jun;21(8):657-72.

PMID:
16003449
10.
11.

Prevention of hypertension and its complications: theoretical basis and guidelines for treatment.

Flack JM, Peters R, Shafi T, Alrefai H, Nasser SA, Crook E.

J Am Soc Nephrol. 2003 Jul;14(7 Suppl 2):S92-8. Review.

12.

Pharmacologic treatment of chronic pediatric hypertension.

Robinson RF, Nahata MC, Batisky DL, Mahan JD.

Paediatr Drugs. 2005;7(1):27-40. Review.

PMID:
15777109
13.

The 2000 Canadian recommendations for the management of hypertension: Part one--therapy.

McAlister FA, Levine M, Zarnke KB, Campbell N, Lewanczuk R, Leenen F, Rabkin S, Wright JM, Stone J, Feldman RD, Lebel M, Honos G, Fodor G, Burgess E, Tobe S, Hamet P, Herman R, Irvine J, Culleton B, Petrella R, Touyz R; Canadian Hypertension Recommendations Working Group.

Can J Cardiol. 2001 May;17(5):543-59.

PMID:
11381277
14.

Hypertension in children and adolescents.

Luma GB, Spiotta RT.

Am Fam Physician. 2006 May 1;73(9):1558-68. Review.

15.

Hypertension in people with Type 2 diabetes: knowledge-based diabetes-specific guidelines.

Working Party of the International Diabetes Federation (European Region).

Diabet Med. 2003 Dec;20(12):972-87. Review.

PMID:
14632698
16.

The future of antihypertensive treatment.

Israili ZH, Hernández-Hernández R, Valasco M.

Am J Ther. 2007 Mar-Apr;14(2):121-34. Review.

PMID:
17414579
17.

The management of hypertension in African Americans.

Ferdinand KC, Armani AM.

Crit Pathw Cardiol. 2007 Jun;6(2):67-71. Review.

PMID:
17667868
18.

Managing hypertension using combination therapy.

Frank J.

Am Fam Physician. 2008 May 1;77(9):1279-86. Review.

20.

The metabolic syndrome in hypertension: European society of hypertension position statement.

Redon J, Cifkova R, Laurent S, Nilsson P, Narkiewicz K, Erdine S, Mancia G; Scientific Council of the European Society of Hypertension.

J Hypertens. 2008 Oct;26(10):1891-900. doi: 10.1097/HJH.0b013e328302ca38.

PMID:
18806611

Supplemental Content

Support Center